Sels et Dérivés d’API
Les sels des Ingrédients Pharmaceutiques Actifs (API) sont des composés formés par la réaction d’un acide avec une base, aboutissant à un équilibre ionique. Ces sels améliorent souvent la solubilité et la stabilité des API, facilitant ainsi leur absorption par l’organisme. Les dérivés des API sont des variantes chimiques d’un principe actif qui peuvent présenter des propriétés améliorées ou modifiées afin d’optimiser leur efficacité thérapeutique. Les sels d’API sont utilisés dans la formulation de médicaments oraux, injectables et topiques. De plus, les dérivés d’API peuvent améliorer la pharmacocinétique des médicaments, notamment en permettant une libération contrôlée des substances actives.
Chez CymitQuimica, nous proposons des sels et dérivés d’API avec la pureté et la qualité requises pour la recherche et le développement de formulations pharmaceutiques.
79450 produits trouvés pour "Sels et Dérivés d’API"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Poloxamer Solid
CAS :Nonionic surface-active agents,aromatic or modified aromatic,whether or not put up for retail saleFormule :HO(C2H4O)a(C3H6O)b(C2H4O)aHCouleur et forme :White Cream PowderMasse moléculaire :304.2931Riluzole Related Compound A (4-(Trifluoromethoxy)aniline)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof nesoiFormule :C7H6F3NOCouleur et forme :Colorless Light Yellow LiquidMasse moléculaire :177.13Ticagrelor Related Compound B
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H28F2N6O4SCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :522.58Succinylmonocholine Chloride
CAS :Quaternary ammonium salts and hydroxides, whether or not chemically defined, nesoiFormule :C9H18ClNO4Couleur et forme :White PowderMasse moléculaire :239.09244Chloroquine Related Compound E (N4-(5-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine oxalate)
Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFormule :C20H28ClN3O4Couleur et forme :White SolidMasse moléculaire :409.91Azelastine Related Compound B (N'-(1-methylazepan-4-yl)benzohydrazide hydrochloride)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H21N3O·HClCouleur et forme :White PowderMasse moléculaire :283.8Iso-propyl p-Toluenesulfonate (Isopropyl toluene-4-sulfonate)
CAS :Hydrocarbon derivatives containing only sulfo groups, their salts andestersFormule :C10H14O3SCouleur et forme :Colorless OilMasse moléculaire :214.06637Diltiazem Related Compound A (AS) (trans-diltiazem hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H26N2O4SCouleur et forme :PowderMasse moléculaire :450.982-Amino-5-chlorobenzophenone
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H10ClNOCouleur et forme :Yellow Crystalline PowderMasse moléculaire :231.04509Chlorothiophene Aldehyde (5-chlorothiophene-2-carbaldehyde)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H3ClOSCouleur et forme :Brown LiquidMasse moléculaire :145.95931Lacosamide Related Compound B (2-Acetamido-3-(benzylamino)-3-oxopropyl acetate)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C14H18N2O4Couleur et forme :Off-White SolidMasse moléculaire :278.31 g/molRanolazine Related Compound C (N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H21N3OCouleur et forme :White PowderMasse moléculaire :247.16846Atenolol Related Compound D (2-[4-(3-Chloro-2-hydroxypropoxy)phenyl]acetamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C11H14ClNO3Couleur et forme :White SolidMasse moléculaire :243.06622p-Ranolazine (N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]piperazin-1-yl}acetamide)
CAS :Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C24H33N3O4Couleur et forme :White PowderMasse moléculaire :427.55Citalopram Related Compound H (3-[5-Bromo-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]-N,N-dimethylpropan-1-amine hydrobromide)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C19H21BrFNO·HBrCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :377.07906Oxymetholone Related Compound B (17β-Hydroxy-1-hydroxymethylene-17α-methyl-5α-androstan-3-one)
CAS :Ketone-alcohols and ketone-aldehydes, nesoiFormule :C21H32O3Couleur et forme :Off-White Light Yellow SolidMasse moléculaire :332.48Phthalazine
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C8H6N2Couleur et forme :Light Yellow PowderMasse moléculaire :130.0531Adapalene Related Compound D (4,4'-dimethoxy-3,3'-di(adamant-1-yl)biphenyl)
CAS :Aromatic ethers and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C34H42O2Couleur et forme :PowderMasse moléculaire :482.31848Phenylephrine Related Compound G ((R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormule :C11H15NO4Couleur et forme :White PowderMasse moléculaire :225.25Mirtazapine Related Compound D (2-Methyl-1,2,3,4-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(14bH)-one)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C17H17N3OCouleur et forme :White Pale Yellow SolidMasse moléculaire :279.13716Cinacalcet Related Compound C ((R)-N-[1-(Naphthalen-1-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propan-1-amine hydrochloride)
CAS :Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormule :C22H22F3NHClCouleur et forme :PowderMasse moléculaire :357.17043Alclometasone Dipropionate Related Compound A (11β,17,21-Trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C28H38O7Couleur et forme :PowderMasse moléculaire :486.26175Sumatriptan Succinate Related Impurities
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White Off-White PowderLosartan Related Compound E (4'-[({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-2H-tetrazol-2-yl)methyl]-4-chloro-1H-imidazol-1- yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C44H43Cl2KN12OCouleur et forme :PowderMasse moléculaire :864.26969Dantrolene Related Compound B (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone)
CAS :Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFormule :C14H12N4O6Couleur et forme :Yellow PowderMasse moléculaire :332.07568Levofloxacin Related Compound B ((S)-9,10,difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C13H9F2NO4Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :281.21Voriconazole Related Compound A ((2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H14F3N5OCouleur et forme :Light Yellow PowderMasse moléculaire :349.11504Aminophenylmorpholinone (4-(4-aminophenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C10H12N2O2Couleur et forme :White Off-White SolidMasse moléculaire :192.22Trazodone Related Compound F (1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C13H18Cl2N2·ClHCouleur et forme :White PowderMasse moléculaire :308.06138Dalfampridine Related Compound B (3,5-Dibromopyridin-4-amine)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C5H4Br2N2Couleur et forme :Off-White SolidMasse moléculaire :249.87412Palonosetron Related Compound E (2-[(3S)-Quinuclidin-3-yl]-2,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-1-one hydrochloride)
CAS :Lactams, nesoiFormule :C19H22N2O·HClCouleur et forme :Yellow SolidMasse moléculaire :330.14989Exemestane Related Compound A (6-Methyleneandrosta-4-ene-3,17-dione)
CAS :Cyclanic, cyclenic or cycloterpenic ketones without othFormule :C20H26O2Couleur et forme :PowderMasse moléculaire :298.42Guanylmelamine Dinitrate (1-(4,6-diamino-1,3,5-triazin-2-yl)guanidine, nitrate)
CAS :Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C4H8N8·2HNO3Couleur et forme :Off-White SolidMasse moléculaire :168.08719Perindopril Related Compound E ((2S,3aS,7aS)-1-{(S)-2-[(S)-1-Isopropoxy-1-oxopentan-2-ylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid, tert-butylamine)
Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C20H34N2O5·C4H11NCouleur et forme :White PowderMasse moléculaire :382.24677Ibuprofen Related Compound C (4-isobutylacetophenone)
CAS :Aromatic ketones without other oxygen function, nesoiFormule :C12H16OCouleur et forme :Clear Colourless To Light Yellow LiquidMasse moléculaire :176.12012Ulipristal Acetate Related Compound A (11β-[4-(Dimethylamino)phenyl]-5α-hydroxy-20-oxospiro{19-norpregna-9-en-3,2'-[1,3]dioxolan}-17-yl acetate)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C32H43NO6Couleur et forme :Light Grey Blue PowderMasse moléculaire :537.30904Nifedipine Nitrophenylpyridine Analog (Dimethyl 4-(2-nitrophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H16N2O6Couleur et forme :White Yellow PowderMasse moléculaire :344.33Benazepril Related Compound C ((S)-2-{[(S)-1-(Carboxymethyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl]amino}-4-phenylbutanoic acid)
CAS :Lactams, nesoiFormule :C22H24N2O5Couleur et forme :White Clumpy PowderMasse moléculaire :396.16852Rivaroxaban Related Compound J
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C38H36Cl2N6O10S2Couleur et forme :Off-White PowderMasse moléculaire :870.13114Levofloxacin Related Compound E ((S)-9-Fluoro-2,3-dihydro-3-methyl-10-[2-(methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H18FN3O4·HClCouleur et forme :Off-White Yellow PowderMasse moléculaire :371.10481Dalfampridine Related Compound C (1,3-Di(pyridin-4-yl)urea)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C11H10N4OCouleur et forme :White SolidMasse moléculaire :214.08546Bimatoprost Related Compound A ((E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]-N-ethylhept-5-enamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C25H37NO4Couleur et forme :LiquidMasse moléculaire :415.27226Cephalexin Related Compound F ((6R,7R)-7-[(R)-2-Amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H17N3O4SCouleur et forme :White Off-White PowderMasse moléculaire :347.39Glycopyrrolate Related Compound L (Methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate)
CAS :Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFormule :C14H18O3Couleur et forme :Translucent Light Yellow Liquid ViscousMasse moléculaire :234.29Citalopram Related Compound A (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide)
CAS :Aromatic pesticides with oxygen hetero-atom(s) only neFormule :C20H23FN2O2Couleur et forme :Cream PowderMasse moléculaire :342.41Orphenadrine Related Compound E (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C18H23NOCouleur et forme :Light Yellow LiquidMasse moléculaire :269.17796Trihexyphenidyl Related Compound A (1-Phenyl-3-(piperidin-1-yl)propan-1-one hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C14H19NO·HClCouleur et forme :SolidMasse moléculaire :253.8Perindopril Related Compound K ((3S,5aS,9aS,10aS)-3-methyldecahydropyrazino[1,2-a]indole-1,4-dione)
CAS :Lactams, nesoiFormule :C12H18N2O2Couleur et forme :White PowderMasse moléculaire :222.29Raloxifene Related Compound C (1-(2-{4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phenoxy}ethyl)piperidine 1-oxide monohydrate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C28H27NO5SCouleur et forme :Yellow PowderMasse moléculaire :489.16099Ketamine Related Compound A (1-[(2-Chlorophenyl)(methylimino)methyl]cylcopentanol)
CAS :Aromatic imines and their derivatives, salts thereofFormule :C13H16NOClCouleur et forme :Off-White PowderMasse moléculaire :237.09204Risperidone Related Compound G (3-{2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C23H28FN3O3Couleur et forme :Off-White PowderMasse moléculaire :413.21147Risedronate Related Compound B ([3,6-Bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid] disodium tetrahydrate salt)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H16N2O12P4Na2·4H2OCouleur et forme :White Fine PowderMasse moléculaire :527.96537Melengestrol Acetate Related Compound A (16-Methylene-3,20-dioxopregn-4-en-17-yl acetate)
CAS :Estrogens and progestinsFormule :C24H32O4Couleur et forme :Pale Yellow Off-White PowderMasse moléculaire :384.23006Olanzapine Related Compound A (5-Methyl-2-((2-nitrophenyl)amino)-3-thiophenecarbonitrile)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H9N3O2SCouleur et forme :Red Brown Orange Dark Red PowderMasse moléculaire :259.04155Trifluridine Related Compound A (5-Carboxy-2'-deoxyuridine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C10H12N2O7Couleur et forme :White Off-White PowderMasse moléculaire :272.06445Letrozole Related Compound A (4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H11N5Couleur et forme :White Off-White PowderMasse moléculaire :285.31Fluorescein Related Compound C (2-(2,4-Dihydroxybenzoyl)benzoic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C14H10O5Couleur et forme :Off-White Pale Yellow PowderMasse moléculaire :258.05282Voriconazole Related Compound F ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfonic acid)
CAS :Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormule :C10H16O4SCouleur et forme :White PowderMasse moléculaire :232.31,3-Dinitroglycerin
CAS :Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFormule :C3H6N2O7Couleur et forme :Clear Colorless LiquidMasse moléculaire :182.0175Norelgestromin Related Compound A (13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-5(6)-en-20-yn-3-one oxime)
CAS :Estrogens and progestinsFormule :C21H29NO2Couleur et forme :SolidMasse moléculaire :327.51Doxepin Related Compound B ((11RS)-11-[3-(dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C19H23NO2Couleur et forme :White Off-White PowderMasse moléculaire :297.39Paliperidone Related Compound C (3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C11H15ClN2O2Couleur et forme :Off-White Crystalline PowderMasse moléculaire :242.082215-Phenylhydantoin
CAS :Hydantoin and its derivativesFormule :C9H8N2O2Couleur et forme :PowderMasse moléculaire :176.05858Methylphenidate Related Compound A (α-Phenyl-2-piperidineacetic Acid Hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C13H17NO2·HClCouleur et forme :White PowderMasse moléculaire :255.10261Ibuprofen Related Compound J (2-(4-Isobutyrylphenyl)propanoic acid)
CAS :Aromatic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids etc not elsewhere specified or includedFormule :C13H16O3Couleur et forme :Brown SolidMasse moléculaire :220.10994Chloropropiophenone (1-(3-Chlorophenyl)propan-1-one)
CAS :Aromatic ketones without other oxygen function, nesoiFormule :C9H9ClOCouleur et forme :White Yellow SolidMasse moléculaire :168.03419Enalapril Related Compound D ((S)-Ethyl 2-[(3S,8aS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutanoate)
CAS :Lactams not elsewhere specified or includedFormule :C20H26N2O4Couleur et forme :Off-White SolidMasse moléculaire :358.43Nabumetone Related Compound A (1-(6-methoxy-2-naphthyl)-but-1-en-3-one)
CAS :Ketone-phenols and ketones with other oxygen functionFormule :C15H14O2Couleur et forme :Light Yellow PowderMasse moléculaire :226.09938Argatroban
CAS :Sulfonamides used as drugsFormule :C23H36N6O5S·H2OCouleur et forme :White Off-White PowderMasse moléculaire :526.25735Bis(2-ethylhexyl)maleate (Maleic acid, bis(2-ethylhexyl)ester)
CAS :Maleic acid not in us note 3 section 6Formule :C20H36O4Couleur et forme :LiquidMasse moléculaire :340.51Fexofenadine Related Compound B (2-(3-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride monohydrate)
Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C32H39NO4·HCl·H2OCouleur et forme :White PowderMasse moléculaire :555.27515o-Flutamide
Aromatic cyclic amides (including cyclic carbamates) anFormule :C11H11F3N2O3Couleur et forme :PowderMasse moléculaire :276.22Ranitidine Related Compound A (5-{[(2-Aminoethyl)thio]methyl}-N,N-dimethyl-2-furanmethanamine hemifumarate)
CAS :Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormule :C10H18N2OSC4H4O4Couleur et forme :Off-White Crystalline PowderMasse moléculaire :272.36Sulindac Related Compound C ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylthio)benzylidene]-1H-inden-3-yl}acetic acid)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C20H17FO2SCouleur et forme :Yellow PowderMasse moléculaire :340.41Capecitabine Related Compound B (5'-deoxy-5-fluorouridine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C9H11FN2O5Couleur et forme :White PowderMasse moléculaire :246.0652Oxacillin Related Compound C (5-Methyl-3-phenylisoxazole-4-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C11H9NO3Couleur et forme :Off-White PowderMasse moléculaire :203.2 g/molLosartan Related Compound D (5-[4'-({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C44H43Cl2KN12OCouleur et forme :PowderMasse moléculaire :865.9Rivaroxaban Related Compound B ((S)-N-({2-Oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)acetamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19N3O5Couleur et forme :White Off-White SolidMasse moléculaire :333.34Ketorolac Related Compound D (5-benzoyl-2,3-dihydro-1H-pyrrolizine)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H13NOCouleur et forme :White Light Brown PowderMasse moléculaire :211.26Trisalicylic Acid
CAS :Esters of salicylic acid and its salts not elsewhere specified or includedFormule :C21H14O7Couleur et forme :White PowderMasse moléculaire :378.34Anagrelide Related Compound C (Ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate)
CAS :Drugs containing a pyrimidine ring (whether or not hydrFormule :C12H13Cl2N3O2·HBrCouleur et forme :Light Yellow PowderMasse moléculaire :301.03848Triamterene Related Compound B (2,7-diamino-4-hydroxy-6-phenylpteridine)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C12H10N6OCouleur et forme :Light Yellow Crystalline PowderMasse moléculaire :254.09161Risedronate Related Compound C ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid))
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C7H11NO6P2Couleur et forme :White Crystalline PowderMasse moléculaire :267.11Ticlopidine Related Compound B (5-(2-chlorobenzyl)-4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H12ClNOSCouleur et forme :White PowderMasse moléculaire :277.77Oxybutynin Related Compound A (Phenylcyclohexylglycolic Acid)
CAS :Carboxylic acids w/ alcohol function but w/o other oxygFormule :C14H18O3Couleur et forme :White Crystalline PowderMasse moléculaire :234.12559Bupivacaine Related Compound A (6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide) (AS)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C18H30N2OCouleur et forme :White Off-White PowderMasse moléculaire :290.23581Ziprasidone Related Compound F (Sodium 2-(2-amino-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-4-chlorophenyl)acetate monohydrate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H22ClN4NaO2S·H2OCouleur et forme :White Off-White SolidMasse moléculaire :470.11553Timolol Related Compound D (4-Morpholino-1,2,5-thiadiazol-3-ol)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C6H9N3O2SCouleur et forme :White Off-White PowderMasse moléculaire :187.04155Fluvastatin Related Compound B ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1, dimethylethyl ester)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C28H34FNO4Couleur et forme :PowderMasse moléculaire :467.24719Pancuronium Bromide Related Compound C (1,1'-(3α-acetoxy-17β-hydroxy-5α-androstan-2β,16β-ylene) bis(1-methylpiperidinium) dibromide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C33H58N2O3·2BrCouleur et forme :White Crystalline PowderMasse moléculaire :690.63 g/mol1-Mononitroglycerin
CAS :Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFormule :C3H7NO5Couleur et forme :Clear Colorless LiquidMasse moléculaire :137.03242Articaine Related Compound B (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H18N2O3SCouleur et forme :PowderMasse moléculaire :270.35Clindamycin 2,3-Dipalmitate (Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside 2,3-dipalmitate monohydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C50H93ClN2O7S·HClCouleur et forme :White Off-White SolidMasse moléculaire :936.61588Roflumilast Related Compound D (3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormule :C12H12F2O4Couleur et forme :Yellow White PowderMasse moléculaire :258.07037Trandolapril Related Compound A ((2S,3aR,7aS)-1-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-methyl ester)
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C23H32N2O5Couleur et forme :Crystalline PowderMasse moléculaire :416.51Tiagabine Related Compound A ((R)-ethyl 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylate, hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H29NO2S2·HClCouleur et forme :White PowderMasse moléculaire :440.07Prostaglandin B1 ((13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic acid)
CAS :Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormule :C20H32O4Couleur et forme :White Off-White SolidMasse moléculaire :336.23006Triprolidine Hydrochloride Z-Isomer
Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C19H22N2·HClCouleur et forme :White Crystalline PowderMasse moléculaire :278.1783Triclosan Related Compounds Mixture A
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :Colorless Clear LiquidImiquimod Related Compound D (1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C13H14N4Couleur et forme :Off-White PowderMasse moléculaire :226.12185Acamprosate Related Compound A (3-aminopropane-1-sulfonic acid)
CAS :Acyclic monoamines and their derivatives, nesoiFormule :C3H9NO3SCouleur et forme :PowderMasse moléculaire :139.03031Apixaban Related Compound G (Ethyl 6-[4-(5-bromopentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C27H29BrN4O5Couleur et forme :Cream PowderMasse moléculaire :569.46Prazosin Related Compound D (Furan-2-yl(piperazin-1-yl)methanone)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C9H12N2O2Couleur et forme :Yellow Pale Yellow Crystalline PowderMasse moléculaire :180.21Trimipramine Related Compound A (3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C20H24N2Couleur et forme :Pale Yellow SolidMasse moléculaire :292.19395Amantadine Related Compound A (1-Chloroadamantane)
CAS :Other halogenated derivatives of cyclanic, cyclenic or cycloterpenic hydrocarbons, excluding hexachlorocyclohexaneFormule :C10H15ClCouleur et forme :White CrystalsMasse moléculaire :170.08623Loratadine Related Compound A (8-Chloro-5,6-dihydro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C19H19ClN2Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :310.82 g/molRabeprazole Related Compound B (2-{[(1H-benzo[d]imidazol-2-yl)sulfinyl]methyl}-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide)
CAS :Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormule :C18H21N3O4SCouleur et forme :White PowderMasse moléculaire :375.44Tioconazole Related Compound B (1-{2-(2,4-Dichlorophenyl)-2-[(2,5-dichlorothiophen-3-yl)methoxy]ethyl}-1H-imidazole hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C16H12Cl4N2OS·HClCouleur et forme :PowderMasse moléculaire :419.94244Cefuroxime Axetil E-isomers ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(E)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H22N4O10SCouleur et forme :Pale Yellow PowderMasse moléculaire :510.10566Methoxsalen Related Compound B (4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one)
CAS :Aromatic lactones used as drugsFormule :C13H10O5Couleur et forme :PowderMasse moléculaire :246.05282Progesterone Related Compound H (Pregna-4,6-diene-3,20-dione)
CAS :Estrogens and progestinsFormule :C21H30O2Couleur et forme :Pale Yellow Off-White PowderMasse moléculaire :314.22458Ethyl 4-nitrobenzoate
CAS :Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFormule :C9H9NO4Couleur et forme :Light Yellow PowderMasse moléculaire :195.17Anastrozole Related Compound A (2,2'-(5-methyl-1,3-phenylene)bis(2-methylpropanenitrile))
CAS :Nitrile function compounds, not elsewhere specified orFormule :C15H18N2Couleur et forme :Yellow PowderMasse moléculaire :226.147Hydroxyzine Related Compound A (1-[(4-Chlorophenyl)phenylmethyl]piperazine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C17H19ClN2Couleur et forme :PowderMasse moléculaire :286.83Diphthalimido Morpholinone Analog (2,2'-((2R,2'R)-((4-(3-oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione))
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C32H30N4O8Couleur et forme :Pale Yellow SolidMasse moléculaire :598.20636R-Omeprazole (5-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole, sodium salt)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O3SCouleur et forme :White PowderMasse moléculaire :367.41Ecamsule Related Compound G (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt)
CAS :Halogenated, sulfonated, nitrated or nitrosated derivatFormule :C18H19NaO5SCouleur et forme :White PowderMasse moléculaire :370.4Valacyclovir Related Compound D (2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9yl)methoxy]ethyl N-ethyl-L-valinate)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C15H24N6O4Couleur et forme :White PowderMasse moléculaire :352.1859Acetyl Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate)
CAS :Lactones, nesoiFormule :C27H40O6Couleur et forme :PowderMasse moléculaire :460.64-Chlorobenzophenone (4-Chlorobenzophenone)
CAS :Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormule :C13H9ClOCouleur et forme :White Off-White PowderMasse moléculaire :216.67Efavirenz Related Compound C (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline)
CAS :Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFormule :C13H9ClF3NCouleur et forme :Off-White PowderMasse moléculaire :271.03756Linezolid R-Isomer (N-{[(R)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl}acetamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H20FN3O4Couleur et forme :White Off-White Solid PowderMasse moléculaire :337.14378Cilostazol Related Compound C (1-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butyl)-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one)
CAS :Lactams, nesoiFormule :C31H45N9O2Couleur et forme :White PowderMasse moléculaire :575.36962Galantamine Hydrobromide Racemic
CAS :Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormule :C17H21NO3·HBrCouleur et forme :White Crystalline PowderMasse moléculaire :287.15214Nimodipine Related Compound A (2-methoxyethyl-1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H24N2O7Couleur et forme :LiquidMasse moléculaire :416.15835Epoprostenol Related Compound A (7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxyoct-1-enyl]cyclopentyl}-6-oxoheptanoic acid)
CAS :Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormule :C20H34O6Couleur et forme :White PowderMasse moléculaire :370.23554Baclofen Related Compound A (4-(4-Chlorophenyl)-2-pyrrolidinone)
CAS :Lactams, nesoiFormule :C10H10ClNOCouleur et forme :White CrystalsMasse moléculaire :195.65Atenolol Related Compound C (2-[4-(Oxiran-2-ylmethoxy)phenyl]acetamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C11H13NO3Couleur et forme :White SolidMasse moléculaire :207.23Rabeprazole Related Compound A (Sodium 1-(1H-benzimidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylate)
Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C14H9N3NaxO3Couleur et forme :Off-White Yellow PowderMasse moléculaire :313.04393Doxazosin Related Compound B (6,7-dimethoxyquinazoline-2,4-dione)
CAS :Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormule :C10H10N2O4Couleur et forme :White PowderMasse moléculaire :222.06406Valacyclovir Related Compound E (2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-benzyloxycarbonyl-L-valinate)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C21H26N6O6Couleur et forme :White Crystalline PowderMasse moléculaire :458.19138Rabeprazole Related Compound E (2-{[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methylthio}benzimidazole)
CAS :Aromatic or modified aromatic heterocyclic compounds wiFormule :C18H21N3O2SCouleur et forme :White Off-White PowderMasse moléculaire :343.13545Megestrol Acetate Related Compound C (6,17a-β-Dimethyl-3,17-dioxo-17a-homoandrosta-4,6-diene-17a-α-yl acetate)
CAS :Esters of acetic acid not elsewhere specified or includedFormule :C24H32O4Couleur et forme :PowderMasse moléculaire :386.5Poloxamer Liquid
CAS :Cationic organic surface-active agents,other than aromatic or modified aromatic, whether or not for retail sale, non-ionic, nesoiFormule :HO(C2H4O)12(C3H6O)20(C2H4O)12HCouleur et forme :Clear Cloudy LiquidMasse moléculaire :2090 to 2360Ritonavir Related Compounds Mixture
CAS :Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White Light Yellow PowderTemazepam Related Compound F (7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione)
CAS :Heterocyclic compounds (excluding aromatic or modifiedFormule :C16H13ClN2O2Couleur et forme :White Crystalline PowderMasse moléculaire :300.06656Verapamil Related Compound A (3,4-Dimethoxy-α-[3-(methylamino)propyl]-α-(1-methylethyl)-benzeneacetonitrile monohydrochloride)
CAS :Nitrile function compounds, not elsewhere specified orFormule :C17H26N2O2·HClCouleur et forme :White PowderMasse moléculaire :290.19943Clopidogrel-β-D-glucuronide ((2S,3S,4S,5R,6S)-6-((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H22ClNO8SCouleur et forme :White Off-White SolidMasse moléculaire :483.07547Acetaminophen Related Compound F (p-nitrophenol)
CAS :Halogenated, sulfonated, nitrated or nitrosated derivatives of phenols or phenol-alcohols, nesoiFormule :C6H5NO3Couleur et forme :PowderMasse moléculaire :139.11(Z)-N'-Methylmeloxicam ((Z)-N-(3,5-dimethylthiazol-2(3H)-ylidene)-4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C15H15N3O4S2Couleur et forme :PowderMasse moléculaire :365.43Oxymetazoline Related Compound A (N-(2-Aminoethyl)-2-[4-(tert-butyl)-3-hydroxy-2,6-dimethylphenyl]acetamide hydrochloride)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C16H26N2O2·HClCouleur et forme :White Off-White PowderMasse moléculaire :314.85Phenylephrine Related Compound E (2-[Benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C16H17NO2·HClCouleur et forme :Grey To White PowderMasse moléculaire :291.10261Mirtazapine Related Compound B (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C17H19N3O·H2OCouleur et forme :Off-White White PowderMasse moléculaire :281.15281Terbinafine Related Compound D ((2E)-N,6,6-trimethyl-N-[(4-methylnaphthalen-1-yl)methyl]hept-2-en-4-yn-1-amine hydrochloride)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C22H27N·HClCouleur et forme :White PowderMasse moléculaire :305.21435Nicotine Related Compound B (3-(1-methyl-1H-pyrrol-2-yl)pyridine)
CAS :Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormule :C10H10N2Couleur et forme :Colorless Light Yellow Oily LiquidMasse moléculaire :158.0844Nitrofurfural Diacetate
CAS :Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormule :C9H9NO7Couleur et forme :White Off-White Tan PowderMasse moléculaire :243.0379Methylprednisolone Related Compound C (11β-Hydroxy-6α-methylandrosta-1,4-diene-3,17-dione)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C20H26O3Couleur et forme :PowderMasse moléculaire :314.18819Moxifloxacin Related Compound D (1-Cyclopropyl-8-fluoro-6-methoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
CAS :Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFormule :C21H24FN3O4Couleur et forme :Yellow SolidMasse moléculaire :401.43Gadoteridol Related Compound A (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid)
CAS :Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormule :C17H32N4O7Couleur et forme :White PowderMasse moléculaire :404.2271Zaleplon Related Compound C (7-[3-(N-ethylacetamido)phenyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C17H17N5O2Couleur et forme :PowderMasse moléculaire :323.13822Ciprofloxacin Related Compound A (7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride salt)
Compounds containing a pyrimidine ring (whether or notFormule :C17H18N3O3Cl·HClCouleur et forme :Pale Yellow PowderMasse moléculaire :384.26Clopidogrel Open Ring Hydrochloride (methyl (S)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C15H16ClNO2S·HClCouleur et forme :White Off-White SolidMasse moléculaire :345.03571Cilostazol Related Compound B (6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-1H-quinolin-2-one)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C20H25N5O2Couleur et forme :White Brown PowderMasse moléculaire :367.45Diazepam Related Compound E (6-Chloro-1-methyl-4-phenylquinazolin-2(1H)-one)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C15H11ClN2OCouleur et forme :Off-White PowderMasse moléculaire :270.05599Sotalol Related Compound C (N-{4-[2-(Isopropylamino)ethyl]phenyl}methanesulfonamide hydrochloride)
CAS :Sulfonamides, nesoiFormule :C12H20N2O2S·HClCouleur et forme :White Crystalline PowderMasse moléculaire :292.10123Zolmitriptan Related Compound G ((S)-4-(4-Aminobenzyl)oxazolidin-2-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C10H12N2O2Couleur et forme :Light Brown PowderMasse moléculaire :192.08988Diclofenac Sodium
CAS :Aromatic amino-acids and their esters,other than thoseFormule :C14H11Cl2NO2·NaCouleur et forme :PowderMasse moléculaire :318.00645Losartan Related Compound A (2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde)
CAS :Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormule :C8H11ClN2OCouleur et forme :PowderMasse moléculaire :186.05599Desthiophenerivaroxaban Phthalimodo Analog ((R)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H19N3O6Couleur et forme :White Off-White SolidMasse moléculaire :421.12739Medroxyprogesterone Acetate Related Compound B (17-Hydroxy-6α-methylpregn-4-ene-3,20-dione)
CAS :Estrogens and progestinsFormule :C22H32O3Couleur et forme :White PowderMasse moléculaire :344.49 g/molTorsemide Related Compound C (N-[(ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide)
CAS :Sulfonamides, excluding drugsFormule :C15H18N4O3SCouleur et forme :White Off-White PowderMasse moléculaire :334.10996Olopatadine Related Compound C (11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl acetic acid)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C16H12O4Couleur et forme :Light Yellow PowderMasse moléculaire :268.07356Clopidogrel Bisulfate
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H16ClNO2S·H2SO4Couleur et forme :White Off-White PowderMasse moléculaire :321.05903Vardenafil Related Compound E (2-[2-Ethoxy-5-(piperazin-1-ylsulfonyl)phenyl]-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one)
CAS :Sulfonamides, nesoiFormule :C21H28N6O4SCouleur et forme :White PowderMasse moléculaire :460.18927Aztreonam E-Isomer
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C13H17N5O8S2Couleur et forme :PowderMasse moléculaire :435.27Desloratadine Related Compound F (8-Chloro-6,11-dihydro-11-(N-formyl-4-piperidinylidene) -5H-benzo[5,6]cyclohepta[1,2-b]pyridine)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C20H19ClN2OCouleur et forme :White SolidMasse moléculaire :338.83Voriconazole Related Compound B ((2S, 3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol)
CAS :Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C16H14F3N5OCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :349.11504Testosterone Enanthate Related Compound G (Androst-4,9(11)-dien-3-one-17β-yl heptanoate)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C26H38O3Couleur et forme :White Waxy SolidMasse moléculaire :398.59Clomipramine Related Compound D (3-(3,7-Dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride)
CAS :Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormule :C19H22Cl2N2·HClCouleur et forme :Off-White Pale Yellow Crystalline PowderMasse moléculaire :387.76 g/molDesthiophenerivaroxaban Methylcarbamate Analog (methyl ((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)carbamate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19N3O6Couleur et forme :White Off-White SolidMasse moléculaire :349.12739Bisoctrizole Related Compound A (2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl) phenol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C20H25N3OCouleur et forme :SolidMasse moléculaire :323.19976Clopidogrel R-Enantiomer ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C15H15ClN2OSCouleur et forme :White Off-White SolidMasse moléculaire :306.81Cefadroxil Related Compound D ((6R,7R)-7-[(S)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
CAS :Aminoglycoside antibioticsFormule :C16H17N3O5SCouleur et forme :White PowderMasse moléculaire :363.39Trandolapril Related Compound E ((2S,3aR,7aS)-1-[N-[(S)-1-Carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C22H30N2O5Couleur et forme :PowderMasse moléculaire :402.21547Zolmitriptan Related Compound E ((S)-N,N-dimethyl-2-{5-[(2-oxooxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H21N3O3Couleur et forme :Off-White PowderMasse moléculaire :303.15829Citric Acid
CAS :Citric acid (2-hydroxy-1,2,3-propanetricarboxylic acid)Formule :C6H8O7Couleur et forme :White CrystalsMasse moléculaire :192.12Olanzapine Related Compound B (2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H10N2OSCouleur et forme :Pale Yellow Dark Yellow PowderMasse moléculaire :230.05138Loratadine Related Compound B (8-Chloro-5,6-dihydro-11-(N-methylpiperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C20H21ClN2Couleur et forme :White Crystalline PowderMasse moléculaire :324.13933Iopamidol Related Compound B (N1,N3-Bis(1,3-dihydroxypropan-2-yl)-5-(2-hydroxyacetamido)-2,4,6-triiodoisophthalamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C16H20I3N3O8Couleur et forme :White PowderMasse moléculaire :762.83846Amlodipine Related Compound K (Ethyl 6-(2-chlorophenyl)-8-methyl-3,4,6,7-tetrahydro-2H-benzo[b][1,4]oxazine-5-carboxylate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18ClNO3Couleur et forme :PowderMasse moléculaire :331.09752Loxapine N-Oxide (4-(2-Chlorodibenzo[b,f][1,4]oxazepin-11-yl)-1-methylpiperazine 1-oxide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18ClN3O2Couleur et forme :White Off-White Pale Yellow SolidMasse moléculaire :343.10875Flutamide Related Compound B (N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C9H7F3N2O3Couleur et forme :PowderMasse moléculaire :248.04088Piroctone Related Compound B (4-methyl-6-(2,4,4-trimethylpentyl)-2H-pyran-2-one)
CAS :Heterocyclic compounds with oxygen hetero-atom(s) onlyFormule :C14H22O2Couleur et forme :Colorless LiquidMasse moléculaire :222.16198Zileuton Related Compound A (N-(1-Benzo[b]thien-2-ylethyl) urea)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C11H12N2OSCouleur et forme :White PowderMasse moléculaire :220.29Chloroxylenol Related Compound A (2-chloro-3,5-dimethylphenol)
CAS :Derivatives containing only halogen substitutes and theFormule :C8H9ClOCouleur et forme :White FlakesMasse moléculaire :156.61Lorazepam Related Compound E (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C15H10Cl2N2OCouleur et forme :White PowderMasse moléculaire :305.16Aprepitant Related Compound A (3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C23H21F7N4O3Couleur et forme :White Off-White PowderMasse moléculaire :534.43Dabigatran Etexilate Related Compound A (Ethyl 3-(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C34H40N6O6Couleur et forme :White SolidMasse moléculaire :628.30093Moxifloxacin Related Compound A (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C20H21F2N3O3Couleur et forme :White Off-White PowderMasse moléculaire :389.4Amifostine Thiol (Ethanethiol, 2-[(3-aminopropyl)amino]-, dihydrochloride)
CAS :Organo-sulfur compounds, nesoiFormule :C5H16N2SCl2Couleur et forme :White PowderMasse moléculaire :207.17 g/molFlavoxate Related Compound A (3-Methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylic acid)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C17H12O4Couleur et forme :White Off-White PowderMasse moléculaire :280.28Spironolactone Related Compound C ((2'R)-3',4'-Dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione)
CAS :Lactones, nesoiFormule :C22H30O3Couleur et forme :White PowderMasse moléculaire :342.21949Ethacrynic Acid Related Compound A ((4-Butyryl-2,3-dichlorophenoxy)acetic acid)
CAS :Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormule :C12H12Cl2O4Couleur et forme :Off-White PowderMasse moléculaire :290.01126Milnacipran Related Compound B (1-Phenyl-3-azabicyclo[3.1.0]hexan-2-one)
CAS :Lactams not elsewhere specified or includedFormule :C11H11NOCouleur et forme :White Off-White SolidMasse moléculaire :173.08406Nateglinide Related Compound B (N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine)
CAS :Aromatic cyclic amides (including cyclic carbamates) anFormule :C19H27NO3Couleur et forme :White PowderMasse moléculaire :317.19909Ganciclovir Mono-N-methyl Valinate (2-(RS)-[(Guanin-9-yl)methoxy]-3-hydroxypropyl N-methyl-L-valinate hydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C15H24N6O5·xHClCouleur et forme :White PowderMasse moléculaire :404.1575Ketorolac Related Compound A (5-Benzoyl-N-(1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)-2,3-dihydro-1H-pyrrolizine-1-carboxamide)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C19H22N2O5Couleur et forme :White PowderMasse moléculaire :358.15287N-Nitroso Diclofenac (2-(2-((2,6-dichlorophenyl) (nitroso)amino)phenyl)acetic acid)
CAS :Compounds with other nitrogen function, nesoiFormule :C14H10Cl2N2O3Couleur et forme :Off-White PowderMasse moléculaire :324.00685Orphenadrine Related Compound B (N-Ethyl-N,N-dimethyl-2-[phenyl(o-tolyl)methoxy]ethanaminium chloride; also known as N-Ethyl-N,N-dimethyl-2-[phenyl(2-tolyl)methoxy]ethanaminium chloride)
CAS :Quaternary ammonium salts and hydroxides, whether or not chemically defined, otherFormule :C20H28ClNOCouleur et forme :White Off-White PowderMasse moléculaire :333.9Lindane Related Compound A ((1R,2R,3R,4R,5S,6S)-1,2,3,4,5,6-Hexachlorocyclohexane)
CAS :1,2,3,4,5,6-hexachlorocyclohexaneFormule :C6H6Cl6Couleur et forme :Off-White PowderMasse moléculaire :290.85 g/mol
![Orphenadrine Related Compound E (N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1479053.webp&w=3840&q=75)
![Raloxifene Related Compound C (1-(2-{4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phe…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1598234.webp&w=3840&q=75)
![Risperidone Related Compound G (3-{2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-2-methyl-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1604756.webp&w=3840&q=75)
![Voriconazole Related Compound F ({(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1-yl}methanesulfo…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1718063.webp&w=3840&q=75)
![Risedronate Related Compound C ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid))](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1604643.webp&w=3840&q=75)
![Fluvastatin Related Compound B ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1285964.webp&w=3840&q=75)
![Trimipramine Related Compound A (3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1692710.webp&w=3840&q=75)
![Valacyclovir Related Compound E (2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-benzy…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1707872.webp&w=3840&q=75)
![Oxymetazoline Related Compound A (N-(2-Aminoethyl)-2-[4-(tert-butyl)-3-hydroxy-2,6-dimethylphenyl]…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1486015.webp&w=3840&q=75)
![Mirtazapine Related Compound B (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]be…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1444235.webp&w=3840&q=75)
![Sotalol Related Compound C (N-{4-[2-(Isopropylamino)ethyl]phenyl}methanesulfonamide hydrochloride)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1617430.webp&w=3840&q=75)
![Olopatadine Related Compound C (11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl acetic acid)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1478436.webp&w=3840&q=75)
![Cefadroxil Related Compound D ((6R,7R)-7-[(S)-2-Amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1097148.webp&w=3840&q=75)
![Zolmitriptan Related Compound E ((S)-N,N-dimethyl-2-{5-[(2-oxooxazolidin-4-yl)methyl]-1H-indol-3-y…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1727064.webp&w=3840&q=75)
![Olanzapine Related Compound B (2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1478323.webp&w=3840&q=75)
![Spironolactone Related Compound C ((2'R)-3',4'-Dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-d…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1619039.webp&w=3840&q=75)
